featured
Amivantamab Plus Chemotherapy for NSCLC With EGFR Exon 20 Insertions
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
N. Engl. J. Med 2023 Oct 21;[EPub Ahead of Print], C Zhou, KJ Tang, BC Cho, B Liu, L Paz-Ares, S Cheng, S Kitazono, M Thiagarajan, JW Goldman, JK Sabari, RE Sanborn, AS Mansfield, JY Hung, M Boyer, S Popat, J Mourão Dias, E Felip, M Majem, M Gumus, SW Kim, A Ono, J Xie, A Bhattacharya, T Agrawal, SM Shreeve, RE Knoblauch, K Park, N GirardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.